microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients

References

• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–5.
   PubMed Web of Science ®Google Scholar
• Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Muroi E, et al. Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation. Ann Rheum Dis. 2011;70(1):194–200.
   PubMed Web of Science ®Google Scholar
• Yoshizaki A, Komura K, Iwata Y, Ogawa F, Hara T, Muroi E, et al. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity. J Clin Immunol. 2009;29(2):180–9.
   PubMed Web of Science ®Google Scholar
• Furst DE, Clements PJ. Hypothesis for the pathogenesis of systemic sclerosis. J Rheumatol Suppl. 1997;48:53–7.
   PubMedGoogle Scholar
• Jimenez SA, Piera-Velazquez S. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of systemic sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality? Matrix biology. J Int Soc Matrix Biol. 2016;51:26–36.
   PubMed Web of Science ®Google Scholar
• Desbois AC, Cacoub P. Systemic sclerosis: an update in 2016. Autoimmun Rev. 2016;15(5):417–26.
   PubMed Web of Science ®Google Scholar
• Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007;117(3):557–67.
   PubMed Web of Science ®Google Scholar
• Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013;65(8):1953–62.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Contatore M, Gulli R, Mandich P, Puppo F. Genetic factors and systemic sclerosis. Autoimmun Rev. 2016;15(5):427–32.
   PubMed Web of Science ®Google Scholar
• Makino T, Jinnin M. Genetic and epigenetic abnormalities in systemic sclerosis. J Dermatol. 2016;43(1):10–8.
   PubMed Web of Science ®Google Scholar
• Fuschiotti P. Current perspectives on the immunopathogenesis of systemic sclerosis. ImmunoTargets Ther. 2016;5:21–35.
   PubMed Web of Science ®Google Scholar
• Assadiasl S, Mousavi MJ, Amirzargar A. Antiapoptotic molecule survivin in transplantation: helpful or harmful? J Transplant. 2018;2018:6.
   Web of Science ®Google Scholar
• Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3(8):917–21.
   PubMed Web of Science ®Google Scholar
• Caldas H, Honsey LE, Altura RA. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies. Mol Cancer. 2005;4(1):11.
   PubMedGoogle Scholar
• Badran A, Yoshida A, Ishikawa K, Goi T, Yamaguchi A, Ueda T, et al. Identification of a novel splice variant of the human anti-apoptosis gene survivin. Biochem Biophys Res Commun. 2004;314(3):902–7.
   PubMed Web of Science ®Google Scholar
• Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 1999;59(24):6097–102.
   PubMed Web of Science ®Google Scholar
• Andersson SE, Svensson MN, Erlandsson MC, Dehlin M, Andersson KM, Bokarewa MI. Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis. PLoS One. 2012;7(10):e47668.
   PubMed Web of Science ®Google Scholar
• Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer. 2003;3(1):46–54.
   PubMed Web of Science ®Google Scholar
• Ebrahimiyan H, Aslani S, Rezaei N, Jamshidi A, Mahmoudi M. Survivin and autoimmunity; the ins and outs. Immunol Lett. 2018;193:14–24.
   PubMed Web of Science ®Google Scholar
• Araujo CL, Quintero IB, Kipar A, Herrala AM, Pulkka AE, Saarinen L, et al. Prostatic acid phosphatase is the main acid phosphatase with 5′-ectonucleotidase activity in the male mouse saliva and regulates salivation. Am J Physiol Cell Physiol. 2014;306(11):C1017–27.
   PubMed Web of Science ®Google Scholar
• Mousavi MJ, Jamshidi A, Chopra A, Aslani S, Akhlaghi M, Mahmoudi M. Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis. J Cell Physiol. 2019;234(1):335–47.
   Web of Science ®Google Scholar
• Fathollahi A, Aslani S, Jamshidi A, Mahmoudi M. Epigenetics in osteoarthritis: novel spotlight. J Cell Physiol. 2019;234(8):12309–24.
   PubMed Web of Science ®Google Scholar
• Soltanzadeh-Yamchi M, Shahbazi M, Aslani S, Mohammadnia-Afrouzi MJB. MicroRNA signature of regulatory T cells in health and autoimmunity. Biomed Pharmacother. 2018;100:316–23.
   PubMed Web of Science ®Google Scholar
• Aslani S, Sobhani S, Gharibdoost F, Jamshidi A, Mahmoudi M. Epigenetics and pathogenesis of systemic sclerosis; the ins and outs. Hum Immunol. 2018;79(3):178–87.
   PubMed Web of Science ®Google Scholar
• Foma AM, Aslani S, Karami J, Jamshidi A, Mahmoudi M. Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous. Inflamm Res. 2017;66(12):1057–73.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Aslani S, Nicknam MH, Karami J, Jamshidi A. New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. Mod Rheumatol. 2017;27(2):198–209.
   PubMed Web of Science ®Google Scholar
• Aslani S, Mahmoudi M, Karami J, Jamshidi AR, Malekshahi Z, Nicknam M. Epigenetic alterations underlying autoimmune diseases. Autoimmunity. 2016;49(2):69–83.
   PubMed Web of Science ®Google Scholar
• Li H, Yang R, Fan X, Gu T, Zhao Z, Chang D, et al. MicroRNA array analysis of microRNAs related to systemic scleroderma. Rheumatol Int. 2012;32(2):307–13.
   PubMed Web of Science ®Google Scholar
• Huang X-L, Zhang L, Li J-P, Wang Y-J, Duan Y, Wang J. MicroRNA-150: a potential regulator in pathogens infection and autoimmune diseases. Autoimmunity. 2015;48(8):503–10.
   PubMed Web of Science ®Google Scholar
• van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–47.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–8.
   PubMed Web of Science ®Google Scholar
• Ebrahimiyan H, Rezaei N, Vojdanian M, Aslani S, Jamshidi A, Mahmoudi M. microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients. Int J Rheum Dis. 2019;22(6):1107–14.
   PubMed Web of Science ®Google Scholar
• Koike Y, Muroi E, Yoshizaki A, Ogawa F, Yanaba K, Takenaka M, et al. Autoantibody against survivin in patients with systemic sclerosis. J Rheumatol. 2010;37(9):1864–70.
   PubMed Web of Science ®Google Scholar
• Mokuda S, Miyazaki T, Ubara Y, Kanno M, Sugiyama E, Takasugi K, et al. CD1a + survivin + dendritic cell infiltration in dermal lesions of systemic sclerosis. Arthritis Res Ther. 2015;17:275.
   PubMed Web of Science ®Google Scholar
• Bokarewa M, Lindblad S, Bokarew D, Tarkowski A. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther. 2005;7(2):R349–58.
   PubMed Web of Science ®Google Scholar
• Mokuda S, Miyazaki T, Ito Y, Yamasaki S, Inoue H, Guo Y, et al. The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes. Sci Rep. 2015;5(1):9795.
   PubMedGoogle Scholar
• Mahmoudi MB, Farashahi Yazd E, Gharibdoost F, Sheikhha MH, Karimizadeh E, Jamshidi A, et al. Overexpression of apoptosis-related protein, survivin, in fibroblasts from patients with systemic sclerosis. Ir J Med Sci. 2019.
   PubMed Web of Science ®Google Scholar
• Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med. 2006;354(25):2667–76.
   PubMed Web of Science ®Google Scholar
• Duncan MR, Berman B. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Investig Dermatol. 1991;97(4):686–92.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Sato S, Takehara K. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. Arch Dermatol Res. 2004;296(2):89–93.
   PubMed Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516.
   PubMed Web of Science ®Google Scholar
• Bagnato G, Roberts WN, Roman J, Gangemi S. A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis. Eur Respir Rev. 2017;26(144):160125.
   PubMed Web of Science ®Google Scholar
• Boidot R, Végran F, Lizard-Nacol S. Transcriptional regulation of the survivin gene. Mol Biol Rep. 2014;41(1):233–40.
   PubMed Web of Science ®Google Scholar
• Manesh PV, Farazmand A, Gharibdoost F, Vanaki N, Mostafaei S, Kavosi H, et al. Downregulation of miR-542-3p contributes to apoptosis resistance in dermal fibroblasts from systemic sclerosis patients via Survivin overexpression. Iran J Allergy Asthma Immunol. 2019;18:173–81.
   PubMed Web of Science ®Google Scholar